Adiponectin in childhood

Alison N. Jeffery, Michael J. Murphy, Brad S. Metcalf, Joanne Hosking, Linda D. Voss, Patrick English, Naveed Sattar, Terence J. Wilkin

    Research output: Contribution to journalReview articlepeer-review

    42 Citations (Scopus)

    Abstract

    Adiponectin, a hormone produced and secreted by adipocytes, is present in circulation in high circulating concentrations, suggesting an important physiological role. An indirect regulator of glucose metabolism, adiponectin increases insulin sensitivity, improves glucose tolerance and inhibits inflammation. Plasma adiponectin relates inversely to adiposity and, importantly, reflects the sequelae of accumulation of excess adiposity. The role of adiponectin in adults has been explored in detail. Studies in children are now available and, given the increasing rates of childhood obesity, it is important to establish the role of adiponectin in mediating insulin resistance and cardiovascular disease in this age group. This paper reviews the regulation of adiponectin, its effect on body mass, glucose metabolism and cardiovascular risk in infants, children and adolescents. It demonstrates clear links between adiponectin and features of the metabolic syndrome in obese children and adolescents. However, adiponectin's role as a predictor of metabolic dysfunction in healthy, normal-weight youngsters is less clear.

    Original languageEnglish
    Pages (from-to)130-140
    Number of pages11
    JournalInternational Journal of Pediatric Obesity
    Volume3
    Issue number3
    DOIs
    Publication statusPublished - 2008

    Cite this